These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17391962)

  • 21. Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.
    Zhou Z; Zhen J; Karpowich NK; Law CJ; Reith ME; Wang DN
    Nat Struct Mol Biol; 2009 Jun; 16(6):652-7. PubMed ID: 19430461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor.
    Wu YJ; He H; Gao Q; Wu D; Bertekap R; Westphal RS; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1611-4. PubMed ID: 24507922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
    Nencetti S; Mazzoni MR; Ortore G; Lapucci A; Giuntini J; Orlandini E; Banti I; Nuti E; Lucacchini A; Giannaccini G; Rossello A
    Eur J Med Chem; 2011 Mar; 46(3):825-34. PubMed ID: 21272963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isochromanes related to fluoxetine].
    Unterhalt B; Heppert U
    Pharmazie; 2001 Jun; 56(6):445-7. PubMed ID: 11446162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical and structural investigation of the paroxetine-human serotonin transporter complex.
    Coleman JA; Navratna V; Antermite D; Yang D; Bull JA; Gouaux E
    Elife; 2020 Jul; 9():. PubMed ID: 32618269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity studies of benzyl ester meperidine and normeperidine derivatives as selective serotonin transporter ligands.
    Gu X; Izenwasser S; Wade D; Housman A; Gulasey G; Rhoden JB; Savoie CD; Mobley DL; Lomenzo SA; Trudell ML
    Bioorg Med Chem; 2010 Dec; 18(23):8356-64. PubMed ID: 20980153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.
    Kumar V; Yarravarapu N; Lapinsky DJ; Perley D; Felts B; Tomlinson MJ; Vaughan RA; Henry LK; Lever JR; Newman AH
    J Med Chem; 2015 Jul; 58(14):5609-19. PubMed ID: 26153715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations.
    Bundgaard C; Sveigaard C; Brennum LT; Stensbøl TB
    Xenobiotica; 2012 Mar; 42(3):256-65. PubMed ID: 22017605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1.
    Herold F; Chodkowski A; Izbicki Ł; Król M; Kleps J; Turło J; Nowak G; Stachowicz K; Dybała M; Siwek A
    Eur J Med Chem; 2009 Apr; 44(4):1710-7. PubMed ID: 18995929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.
    Hanna MM; Eid NM; George RF; Safwat HM
    Bioorg Med Chem; 2007 Dec; 15(24):7765-72. PubMed ID: 17870537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of peptide combinatorial libraries in drug design: the identification of a potent serotonin reuptake inhibitor derived from a tripeptide cassette library.
    Koppel G; Dodds C; Houchins B; Hunden D; Johnson D; Owens R; Chaney M; Usdin T; Hoffman B; Brownstein M
    Chem Biol; 1995 Jul; 2(7):483-7. PubMed ID: 9383450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.
    Angus D; Bingham M; Buchanan D; Dunbar N; Gibson L; Goodwin R; Haunsø A; Houghton A; Huggett M; Morphy R; Napier S; Nimz O; Passmore J; Walker G
    Bioorg Med Chem Lett; 2011 Jan; 21(1):271-5. PubMed ID: 21112782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
    Pinheiro IL; da Silva AI; Reginato A; da Silva Filho RC; Galindo LCM; Matos RJB; de Souza Ferraz JC; Toscano Meneses da Silva Castro AE; Milanski Ferreira M; Manhães de Castro R; de Souza SL
    Behav Brain Res; 2019 Jan; 357-358():65-70. PubMed ID: 28756214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL; Chen XF; Ran YH; Li XR; Xiong J; Zheng YY; Gao NN; Li YF
    Sci Rep; 2017 Aug; 7(1):8631. PubMed ID: 28819255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
    Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (11) C and (18) F PET radioligands for the serotonin transporter (SERT).
    Stehouwer JS; Goodman MM
    J Labelled Comp Radiopharm; 2013; 56(3-4):114-9. PubMed ID: 24285317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.